This is a Validated Antibody Database (VAD) review about human TRAF1, based on 5 published articles (read how Labome selects the articles), using TRAF1 antibody in all methods. It is aimed to help Labome visitors find the most suited TRAF1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TRAF1 synonym: EBI6; MGC:10353; TNF receptor-associated factor 1; Epstein-Bar virus-induced protein 6

Invitrogen
rabbit monoclonal (K.915.10)
  • immunohistochemistry; human; 1:50; tbl 2
In order to evaluate the reliance on EBV or NF-kappaB signaling instead of B-cell receptor signaling in regards to complete phenotypic characterization of PTLD, Invitrogen TRAF1 antibody (Thermo, MA5-15043) was used in immunohistochemistry on human samples at 1:50 (tbl 2). Hematol Oncol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-3)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology TRAF1 antibody (SCBT, h3) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
Cell Signaling Technology
rabbit monoclonal (45D3)
  • western blot; human; loading ...; fig s12d
Cell Signaling Technology TRAF1 antibody (Cell Signaling, #4715) was used in western blot on human samples (fig s12d). Proc Natl Acad Sci U S A (2018) ncbi
rabbit monoclonal (45D3)
  • flow cytometry; human; loading ...; fig 9a
Cell Signaling Technology TRAF1 antibody (Cell Signaling, 45D3) was used in flow cytometry on human samples (fig 9a). J Virol (2018) ncbi
rabbit monoclonal (45D3)
  • immunohistochemistry; human; fig 3
Cell Signaling Technology TRAF1 antibody (Cell signaling Tech, 45D3) was used in immunohistochemistry on human samples (fig 3). Clin Cancer Res (2015) ncbi
Articles Reviewed
  1. Harper C, Woodcock D, Lam C, Garcia Albornoz M, Adamson A, Ashall L, et al. Temperature regulates NF-?B dynamics and function through timing of A20 transcription. Proc Natl Acad Sci U S A. 2018;115:E5243-E5249 pubmed publisher
  2. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  3. Menter T, Dickenmann M, Juskevicius D, Steiger J, Dirnhofer S, Tzankov A. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. Hematol Oncol. 2017;35:187-197 pubmed publisher
  4. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  5. Lassen U, Meulendijks D, Siu L, Karanikas V, Mau Sorensen M, Schellens J, et al. A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers. Clin Cancer Res. 2015;21:258-66 pubmed publisher